June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Prevalence of Refractive Error in Inherited Retinal Dystrophies
Author Affiliations & Notes
  • Shaden Yassin
    Ophthalmology, University of California at San Diego Department of Ophthalmology at the Shiley Eye Institute, La Jolla, California, United States
  • Evan Walker
    Ophthalmology, University of California at San Diego Department of Ophthalmology at the Shiley Eye Institute, La Jolla, California, United States
  • Shyamanga Borooah
    Ophthalmology, University of California at San Diego Department of Ophthalmology at the Shiley Eye Institute, La Jolla, California, United States
  • Footnotes
    Commercial Relationships   Shaden Yassin None; Evan Walker None; Shyamanga Borooah None
  • Footnotes
    Support  UCSD Vision research core grant (P30EY022589) and Foundation Fighting Blindness CD-GT-0918-0746-SEI
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 619 – A0334. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Shaden Yassin, Evan Walker, Shyamanga Borooah; Prevalence of Refractive Error in Inherited Retinal Dystrophies. Invest. Ophthalmol. Vis. Sci. 2022;63(7):619 – A0334.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Ametropia has been associated with Inherited Retinal Dystrophies (IRDs). However, the prevalence of ametropia in IRDs and its genetic associations is poorly studied. We aim to address this knowledge gap by studying refractive error in a cohort of IRD patients at an academic ophthalmology referral center.

Methods : We performed a single center cross-sectional retrospective study of cases identified from the IRD database of the Shiley Eye Institute, University of California San Diego, containing all patients seen in the dystrophy clinic. Patients were included with clinical and molecular confirmed IRD. Demographic and clinical data retrieved from medical records included age, gender, disease phenotype, best corrected visual acuity, objective and subjective refraction. Distributions and mean spherical equivalent (SE) were calculated for causal genes. Analysis of SE was conducted on a per subject eye level through Linear Mixed Effects modeling. Statistical analyses were performed using R statistical software (R Version 3.6.3).

Results : The database contained 571 patients with IRD. We represent 162 patients with clinical and molecular confirmed IRD, 82 (51%) were males, mean age was 37.6 years (SD +/-2.4). Of these, 112 patients had refractive data, 61 (54%) were ametropic (Fig. 1). Investigating genes associated with myopia, RPGR (n=10, 6%) had the highest odds ratio of myopia 403.43 (P<0.02; SE 1.90 D [SD 34.20]); followed by NYX (n=3, 2%)(78.02, P<0.04; SE 2.59 D [SD 46.62]); and ABCA4 (n= 15, 9%)(54.60, P<0.03; SE 2.92 D [SD 52.56]). For genes associated with hyperopia, NMNAT-1 (n= 3, 2%) had the highest odds ratio of hyperopia 971.57 (P<0.001; SE 2.81 D [SD 50.58]); followed by AIPL1 (n= 2, 1%)(405.45, P<0.001; SE 2.92 D [SD 52.56]); and CNGB3 (n= 3, 2%)(40.04, P<0.001; SE 3.17 D [SD 57.06]). n=number of subjects, 2 eyes per subject was used for SE analysis.

Conclusions : Ametropia was commonly seen in IRD patients and appears similarly prevalent as in the unaffected US population which contrasts previous reports. The pattern of error of refraction varied widely by causal gene. Our findings confirm previous reports in some genes such as myopia associated with NYX. However, in our cohort, AIPL1 variants were associated with hyperopia contrasting with previous reports of myopia. Genes identified require further validation in larger cohorts but are candidates for more in-depth investigation in functional studies of refractive error.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×